IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	217.81	176.48	260.29	126.94	91.98
Other Operating Expenses	-2.2	-0.91	3.98	1.85	-8.46
Total Operating Expenses	251.18	175.57	264.27	128.78	83.53
Operating Income	-185.21	-175.57	-264.27	-128.78	-83.53
Interest Expense	-7.04	-26.57	-1.43	-	-
Interest & Investment Income	1.77	4.45	149.37	-	-
Currency Exchange Gain (Loss)	-1.21	1.73	0.47	-2.3	-0.15
Other Non-Operating Income	197.73	-631.73	-267.96	-47.55	-51.63
EBT Excluding Unusual Items	6.04	-827.69	-383.82	-178.63	-135.31
Gain (Loss) on Sale of Investments	10.61	-94.24	230.06	12.76	-
Asset Writedown	-372.78	560.97	1,190	1,478	747.19
Pretax Income	-356.13	-360.96	1,036	1,313	611.88
Income Tax Expense	287.07	-1,338	605.97	-	-
Net Income	-643.2	976.65	430.32	1,313	611.88
Net Income to Common	-643.2	976.65	430.32	1,313	611.88
Net Income Growth	-	126.96%	-67.21%	114.51%	-
Basic Shares Outstanding	167	168	168	168	70
Diluted Shares Outstanding	167	168	168	168	70
Shares Change	-0.21%	-	-	139.29%	-
EPS (Basic)	-3.85	5.83	2.57	7.84	8.74
EPS (Diluted)	-3.85	5.83	2.57	7.84	8.74
EPS Growth	-	126.96%	-67.21%	-10.36%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
EBITDA	-182.91	-173.38	-262.08	-128.13	-83.47
D&A For Ebitda	2.3	2.19	2.19	0.65	0.05
EBIT	-185.21	-175.57	-264.27	-128.78	-83.53
Effective Tax Rate	-	-	58.48%	-	-